Email Us
View Reports

Plasma Fractionation Market

Plasma Fractionation Market Analysis – By Product (Immunoglobulin,Coagulation Factor Concentrates, Albumin, Protease Inhibitors), By Application (Immunology, Neurology, Hematology, Critical Care, Pulmonology, Rheumatology, Hemato-Oncology, Others), By End-User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes, Others), By Region – Global Industry Size, Share, Growth , Trends and Forecast Report 2023

  • ID : 176237892  |  
  • Published : Feb-2022  |  
  • Region : Global  |  
  • Pages : 90   |  
  • Publisher : Market Research Future

In plasma fractionation process protein products are fractionated from human plasma for the prevention, and treatment of life-threatening conditions such as congenital deficiencies, immunologic disorders, and others.

Plasma Fractionation Market Size and Growth Rate:

According to the Research Report, the Global Plasma Fractionation Market Size has valued USD 18,073 Million in 2017 and is projected to grow at a CAGR of 6.5% during the forecast period.

Plasma Fractionation Market - Drivers and Growth:

Rising participation of market players is one of the key factors driving the plasma fractionation market. For instance, in 2018, Grifols acquired 24 plasma donation centres in the United States operated by Biotest Pharmaceuticals Corp. for USD 286 million. With this acquisition, Grifols now owns 249 plasma donation centres to increase its supply of plasma proteins used for therapeutic purposes.

Plasma Fractionation Market - Regional Presence:

Various other factors such as increasing geriatric population, technological advancements, emerging markets in APAC and RoW, rising plasma collection, and increasing prevalence of respiratory and autoimmune disorders are also expected to propel the growth of the market.

The Americas dominated the global market for plasma fractionation owing to the presence of major market players and increasing prevalence of immunodeficiency disorders within the region. According to the 2018 study published in the Allergy, Asthma & Clinical Immunology journal, the estimated overall prevalence of immunoglobulin A (IgA) deficiency in the US was approximately 1 in 300 to 1 in 500 persons.

In 2017, it was estimated that Europe stood second in the global plasma fractionation market. This can be attributed to the increasing technological advancements and rising R&D investments.

The Asia Pacific was projected to be the fastest growing region in 2017. Increasing healthcare expenditure drives the regional markets of the Asia Pacific region. According to the Australian Institute of Health and Welfare, from 2015 to 2016, the total health expenditure was USD 181 billion. Out of this, USD 69 billion was spent on hospitals, which is a real increase of USD 2 billion from the previous year. During the same years, non-government sources spent USD 55.8 billion on health.

Prominent Companies leading the Global Plasma Fractionation Market:

  • Bio Products Laboratory (BPL)
  • Biotest AG
  • China Biologic Products Holdings, Inc.
  • CSL Limited
  • Green Cross Corporation
  • Grifols, S.A.
  • Japan Blood Products Organization
  • Kedrion S.p.A
  • LFB group
  • Octapharma AG
  • Sanquin
  • Shanghai RAAS
  • Shire

Plasma Fractionation Market Detailed Segmentation:

Plasma Fractionation Market - By Product:

  • Immunoglobulin
  • Coagulation Factor Concentrates
  • Albumin
  • Protease Inhibitors

Plasma Fractionation Market - By Application:

  • Immunology
  • Neurology
  • Haematology
  • Critical Care
  • Pulmonology
  • Rheumatology
  • Hemato-Oncology
  • Others

Plasma Fractionation Market - By End User:

  • Hospitals & Clinics
  • Clinical Research Laboratories
  • Academic Institutes
  • Others

Plasma Fractionation Market - By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Intended Audience for Plasma Fractionation Market:

  • Government and Private Laboratories
  • Research and Development (R&D) companies
  • Medical Research Laboratories
  • Market Research and Consulting Service Providers

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Macroeconomic Indicators

4.5 Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Opportunities

5.4 Pricing Analysis

Chapter 6. Global Plasma Fractionation Market, By Product

6.1 Introduction

6.2 Immunoglobulin

6.2.1 Intravenous Immunoglobulin (IVIG)

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

6.2.2 Subcutaneous Immunoglobulin (SCIG)

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

6.2.3 Others

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

6.3 Coagulation Factor Concentrates

6.3.1 Factor VIII

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

6.3.2 Factor IX

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

6.3.3 Von Willebrand Factor

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

6.3.4 Prothrombin Complex Concentrate

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

6.3.5 Fibrinogen Concentrates

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

6.3.6 Factor XIII

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

6.4 Albumin

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

6.5 Protease Inhibitors

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

6.6 Others

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

Chapter 7. Global Plasma Fractionation Market, By Application

7.1 Introduction

7.2 Immunology

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

7.3 Neurology

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

7.4 Hematology

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

7.5 Critical Care

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

7.6 Pulmonology

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

7.7 Rheumatology

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

7.8 Hemato-Oncology

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

7.9 Others

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

Chapter 7. Global Plasma Fractionation Market, By End User

7.1 Introduction

7.2 Hospitals & Clinics

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

7.3 Clinical Research Laboratories

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

7.4 Academic Institutes

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

7.5 Others

Market Estimates & Forecast, By Region, 2018–2023

Market Estimates & Forecast, By Country, 2018–2023

Chapter 8. Global Plasma Fractionation Market, By Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 U.S.

8.2.1.2 Canada

8.2.2 South America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 Italy

8.3.1.4 Spain

8.3.1.5 UK

8.3.1.6 Rest Of Western Europe

8.3.2 Eastern Europe

8.4 Asia-Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 South Korea

8.4.6 Rest Of Asia-Pacific

8.5 Middle East & Africa

8.5.1 Middle East

8.5.2 Africa

Chapter 9. Company Landscape

9.1 Introduction

9.2 Market Share Analysis

9.3 Key Development & Strategies

Chapter 10. Company Profiles

10.1 Bio Products Laboratory (BPL)

10.1.1 Company Overview

10.1.2 Product Overview

10.1.3 Financials Overview

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 Biotest AG

10.2.1 Company Overview

10.2.2 Product Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 China Biologic Products Holdings, Inc.

10.3.1 Company Overview

10.3.2 Product Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 CSL Limited

10.4.1 Company Overview

10.4.2 Product Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 Green Cross Corporation

10.5.1 Company Overview

10.5.2 Product Overview

10.5.3 Financial Overview

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.6 Grifols, S.A.

10.6.1 Company Overview

10.6.2 Product Overview

10.6.3 Financial Overview

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.7 Japan Blood Products Organization

10.7.1 Overview

10.7.2 Product Overview

10.7.3 Financial Overview

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.8 Kedrion S.P.A

10.8.1 Overview

10.8.2 Product Overview

10.8.3 Financials

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.9 LFB Group

10.9.1 Overview

10.9.2 Product Overview

10.9.3 Financials

10.9.4 Key Developments

10.9.5 SWOT Analysis

10.10 Octapharma AG

10.10.1 Overview

10.10.2 Product Overview

10.10.3 Financials

10.10.4 Key Developments

10.10.5 SWOT Analysis

10.11 Sanquin

10.11.1 Overview

10.11.2 Product Overview

10.11.3 Financials

10.11.4 Key Developments

10.11.5 SWOT Analysis

10.12 Shanghai RAAS

10.12.1 Overview

10.12.2 Product Overview

10.12.3 Financials

10.12.4 Key Developments

10.12.5 SWOT Analysis

10.13 Shire

10.13.1 Overview

10.13.2 Product Overview

10.13.3 Financials

10.13.4 Key Developments

10.13.5 SWOT Analysis

10.14 TP Orthodontics

10.14.1 Overview

10.14.2 Product Overview

10.14.3 Financials

10.14.4 Key Developments

10.14.5 SWOT Analysis

10.15 Ultradent Products

10.15.1 Overview

10.15.2 Product Overview

10.15.3 Financials

10.15.4 Key Developments

10.15.5 SWOT Analysis

10.16 Other

Chapter 11 MRFR Conclusion

11.1 Key Findings

11.1.1 From CEO’s Viewpoint

11.1.2 Unmet Needs Of The Market

11.2 Key Companies To Watch

11.3 Predictionsfor The Global Plasma Fractionation Market

Chapter 12 Appendix

LIST OF TABLES

Table 1 Plasma Fractionation Market Synopsis, 2018–2023

Table 2 Plasma Fractionation Market Estimates And Forecast, 2018–2023 (USD Million)

Table 3 Global Plasma Fractionation Market, By Region, 2018–2023 (USD Million)

Table 4 Global Plasma Fractionation Market, By Product, 2018–2023 (USD Million)

Table 5 Global Plasma Fractionation Market, By Application, 2018–2023 (USD Million)

Table 6 Global Plasma Fractionation Market, End User, 2018–2023 (USD Million)

Table 7 North America: Plasma Fractionation Market, By Product, 2018–2023 (USD Million)

Table 8 North America: Plasma Fractionation Market, By Application, 2018–2023 (USD Million)

Table 9 North America: Plasma Fractionation Market, End User, 2018–2023 (USDMillion)

Table 10 US: Plasma Fractionation Market, By Product, 2018–2023 (USD Million)

Table 11 US: Plasma Fractionation Market, By Application, 2018–2023 (USD Million)

Table 12 US: Plasma Fractionation Market, End User, 2018–2023 (USD Million)

Table 13 Canada:Plasma Fractionation Market,By Product, 2018–2023 (USD Million)

Table 14 Canada: Plasma Fractionation Market, By Application, 2018–2023 (USD Million)

Table 15 Canada: Plasma Fractionation Market, End User, 2018–2023 (USDMillion)

Table 16 South America: Plasma Fractionation Market, By Product, 2018–2023 (USD Million)

Table 17 South America: Plasma Fractionation Market, By Application, 2018–2023 (USD Million)

Table 18 South America: Plasma Fractionation Market, End User, 2018–2023 (USDMillion)

Table 19 Europe: Plasma Fractionation Market, By Product, 2018–2023 (USD Million)

Table 20 Europe: Plasma Fractionation Market, By Application, 2018–2023 (USD Million)

Table 21 Europe: Plasma Fractionation Market, End User, 2018–2023 (USD Million)

Table 22 Western Europe: Plasma Fractionation Market, By Product, 2018–2023 (USDMillion)

Table 23 Western Europe: Plasma Fractionation Market, By Application, 2018–2023 (USD Million)

Table 24 Western Europe: Plasma Fractionation Market, By End User, 2018–2023(USD Million)

Table 25 Eastern Europe: Plasma Fractionation Market, By Product, 2018–2023 (USD Million)

Table 26 Eastern Europe: Plasma Fractionation Market, By Application, 2018–2023 (USD Million)

Table 27 Eastern Europe: Plasma Fractionation Market, End User, 2018–2023(USD Million)

Table 28 Asia-Pacific: Plasma Fractionation Market, By Product, 2018–2023 (USD Million)

Table 29 Asia-Pacific: Plasma Fractionation Market, By Application, 2018–2023 (USD Million)

Table 30 Asia-Pacific: Plasma Fractionation Market, End User, 2018–2023 (USD Million)

Table 31 Middle East & Africa: Plasma Fractionation Market, By Product, 2018–2023 (USD Million)

Table 32 Middle East & Africa: Plasma Fractionation Market, By Application, 2018–2023 (USD Million)

Table 33 Middle East & Africa: Plasma Fractionation Market, End User, 2018–2023(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Plasma Fractionation Market

Figure 3 Market Dynamics For Global Plasma Fractionation Market

Figure 4 Plasma Fractionation Market Share, By Product, 2017

Figure 5 Plasma Fractionation Market Share, By Application, 2017

Figure 6 Plasma Fractionation Market Share, End User, 2017

Figure 7 Plasma Fractionation Market Share, By Region, 2017

Figure 8 North America: Plasma Fractionation Market Share, By Country, 2017

Figure 9 Europe: Plasma Fractionation Market Share, By Country, 2017

Figure 10 Asia-Pacific: Plasma Fractionation Market Share, By Country, 2017

Figure 11 Middle East & Africa: Plasma Fractionation Market Share, By Region, 2017

Figure 12 Plasma Fractionation Market: Company Share Analysis, 2017 (%)

Figure 13 Bio Products Laboratory (BPL): Key Financials

Figure 14 Bio Products Laboratory (BPL): Segmental Revenue

Figure 15 Bio Products Laboratory (BPL): Geographical Revenue

Figure 16 Biotest AG: Key Financials

Figure 17 Biotest AG: Segmental Revenue

Figure 18 Biotest AG: Geographical Revenue

Figure 19 China Biologic Products Holdings, Inc.: Key Financials

Figure 20 China Biologic Products Holdings, Inc.: Segmental Revenue

Figure 21 China Biologic Products Holdings, Inc.: Geographical Revenue

Figure 22 CSL Limited: Key Financials

Figure 23 CSL Limited: Segmental Revenue

Figure 24 CSL Limited: Geographical Revenue

Figure 25 Green Cross Corporation: Key Financials

Figure 26 Green Cross Corporation: Segmental Revenue

Figure 27 Green Cross Corporation: Geographical Revenue

Figure 28 Grifols, S.A.: Key Financials

Figure 29 Grifols, S.A.: Segmental Revenue

Figure 30 Grifols, S.A.: Geographical Revenue

Figure 31 Japan Blood Products Organization: Key Financials

Figure 32 Japan Blood Products Organization: Segmental Revenue

Figure 33 Japan Blood Products Organization: Geographical Revenue

Figure 34 Dentsply Sirona: Key Financials

Figure 35 Dentsply Sirona: Segmental Revenue

Figure 36 Dentsply Sirona: Geographical Revenue

Figure 37 Kedrion S.P.A: Key Financials

Figure 38 Kedrion S.P.A: Segmental Revenue

Figure 39 Kedrion S.P.A: Geographical Revenue

Figure 40 LFB Group: Key Financials

Figure 41 LFB Group: Segmental Revenue

Figure 42 LFB Group: Geographical Revenue

Figure 43 Octapharma AG: Key Financials

Figure 44 Octapharma AG:Segmental Revenue

Figure 45 Octapharma AG: Geographical Revenue

Figure 46 Sanquin: Key Financials

Figure 47 Sanquin: Segmental Revenue

Figure 48 Sanquin: Geographical Revenue

Figure 49 Shanghai RAAS: Key Financials

Figure 50 Shanghai RAAS: Segmental Revenue

Figure 51 Shanghai RAAS: Geographical Revenue

Figure 52 Shire: Key Financials

Figure 53 Shire: Segmental Revenue

Figure 54 Shire: Geographical Revenue

Purchase this Market Research Report

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?